Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Nature Metabolism https://doi.org/10.1038/s42255-025-01443-2 
Dr. Yinuo Wang  et al.

Points

Researchers discovered that Lamin A/C acts as a metabolic control center by regulating the flux of cysteine catabolism to maintain proper gene expression during critical stages of heart cell development.
The loss of Lamin A/C leads to an overproduction of cysteine that increases histone acetylation and triggers a premature transition of stem cells into abnormal and nonfunctional cardiovascular cell types.
Toxic mutations in the Lmna gene associated with accelerated aging were found to reduce specific enzyme levels and disrupt the balance of chemical markers on the genome that ensure stability.
Genetic or pharmacological modulation of the enzymes cystathionine gamma lyase and cystathionine beta synthase effectively restored the metabolic balance and rescued the cells from progressive damage and senescent phenotypes.
These results suggest that targeting metabolic pathways provides a promising new therapeutic strategy for treating rare genetic heart conditions and mitigating the effects of aging on the cardiovascular system.

Summary

This study identifies Lamin A/C as a central regulator of cysteine catabolic flux, a metabolic pathway essential for epigenetic stability and myocardial cell longevity. Researchers utilized mouse pluripotent stem cells to demonstrate that the nuclear lamina does more than provide structural support; it serves as a metabolic control center. The loss of Lamin A/C triggers the upregulation of enzymes cystathionine gamma-lyase (CTH) and cystathionine beta-synthase (CBS), significantly promoting de novo cysteine synthesis and altering the cellular metabolic landscape.

The resulting increase in cysteine flux into acetyl-CoA enhances the acetylation of histones H3K9 and H3K27, driving a premature transition from naive to primed pluripotency. Conversely, toxic gain-of-function Lmna mutations—associated with progeroid aging—were found to reduce CTH and CBS levels. This metabolic rerouting disrupts the critical balance between H3K9 acetylation and methylation, directly impacting germ layer formation and decreasing genome stability. Observations of these metabolic shifts indicate that the spatiotemporal interplay between the nuclear lamina and metabolic flux is a primary determinant of cell fate.

Notably, pharmacological or genetic modulation of CTH and CBS successfully rescued abnormal phenotypes in heart cells. Restoration of cysteine catabolism improved DNA damage repair capacity and alleviated senescent markers induced by Lamin A/C mutations. These findings suggest that targeting metabolic pathways rather than direct genetic editing may provide a viable therapeutic strategy for rare laminopathies and age-related cardiovascular decline. The study underscores the potential for metabolic interventions to reprogram the epigenome and stabilize heart cell function in hereditary cardiovascular diseases.

Link to the article: https://www.nature.com/articles/s42255-025-01443-2

References

Wang, Y., Shi, H., Wittig, J., Ren, Y., Cordero, J., Dewenter, M., Mella, J., Buchwalter, A., Backs, J., Wieland, T., Heineke, J., Fleming, I., Bibli, S.-I., & Dobreva, G. (2026). Lamin A/C-regulated cysteine catabolic flux modulates stem cell fate through epigenome reprogramming. Nature Metabolism, 1–23. https://doi.org/10.1038/s42255-025-01443-2